APAC IPOs & Placements, Aequitas Research

Clarence Chu

APAC IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/ysb-inc" target="_blank" data-smartkarma-citation="entities:35982:1" rel="noopener">YSB Inc (YSB HK)</a> is looking to raise about US$500m in its upcoming Hong Kong IPO.  </li>
<li>YSB Inc. (YSB) operates a pharmaceutical platform, digitizing the pharmaceutical transaction and service segment.</li>
<li>However, gross margins have fluctuated owing to a changing sales mix. Growth has also come at the cost of profitability and YSB has consistently burned cash over its track period.</li>
</ul>



YSB Inc (YSB HK) is looking to raise about US$500m in its upcoming Hong Kong IPO.  
YSB Inc. (YSB) operates a pharmaceutical platform, digitizing the pharmaceutical transaction and service segment.
However, gross margins have fluctuated owing to a changing sales mix. Growth has also come at the cost of profitability and YSB has consistently burned cash over its track period.


YSB Inc Pre-IPO - The Negatives - However, It Comes at a Cost to Profitability

<ul>
<li>
<a href="https://www.smartkarma.com/entities/ysb-inc" target="_blank" data-smartkarma-citation="entities:35982:1" rel="noopener">YSB Inc (YSB HK)</a> is looking to raise about US$500m in its upcoming Hong Kong IPO.  </li>
<li>YSB Inc. (YSB) operates a pharmaceutical platform, digitizing the pharmaceutical transaction and service segment.</li>
<li>Throughout its history, YSB has been evolving its business model and has been growing its user base rapidly as well, thereby leading to GMV growth and in turn, sales growth.</li>
</ul>



YSB Inc (YSB HK) is looking to raise about US$500m in its upcoming Hong Kong IPO.  
YSB Inc. (YSB) operates a pharmaceutical platform, digitizing the pharmaceutical transaction and service segment.
Throughout its history, YSB has been evolving its business model and has been growing its user base rapidly as well, thereby leading to GMV growth and in turn, sales growth.


YSB Inc Pre-IPO - The Positives - Evolving Business Model Coupled with Growth.

China

YSB Inc. operates as a digital pharmaceutical platform outside of hospitals in China.. The Company provides outside of hospital pharmaceutical circulation services. YSB mainly offers services to pharmaceutical companies, distributors, vendors, pharmacies, primary healthcare institutions, and others.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

YSB (9885 HK)

YSB Inc Pre-IPO - The Negatives - However, It Comes at a Cost to Profitability

YSB Inc (YSB HK) is looking to raise about US$500m in its upcoming Hong Kong IPO. YSB Inc. (YSB) operates a pharmaceutical platform, digitizing the...

Clarence Chu

YSB Inc Pre-IPO - The Positives - Evolving Business Model Coupled with Growth.

YSB Inc (YSB HK) is looking to raise about US$500m in its upcoming Hong Kong IPO. YSB Inc. (YSB) operates a pharmaceutical platform, digitizing the...

Clarence Chu

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)